Analysis of organ-enriched microRNAs in plasma as an approach to development of Universal Screening Test: Feasibility study

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Sheinerman, Kira S ^a   Tsivinsky, Vladimir G ^a   Umansky, Samuil R ^a  

^a DiamiR LLC   (United States)

Author keywords

Biomarker; Cancer; Circulating miRNA; Gastrointestinal system; Inflammation; miRNA; miRNA pairs; Plasma; Pulmonary system; Screening

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; SILICON DIOXIDE;

ARTICLE; ASTHMA; CELL FREE SYSTEM; COLON CANCER; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS CANCER; FEASIBILITY STUDY; GASTROINTESTINAL DISEASE; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; NEOPLASM; PLASMA; PNEUMONIA; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; UNIVERSAL SCREENING TEST;

EARLY DIAGNOSIS; FEASIBILITY STUDIES; GASTROINTESTINAL DISEASES; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84889860278     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-304     Document Type: Article

References (38)

1. Snyder EM, Olin J, David FS. Maximizing the value of diagnostics in Alzheimer's disease drug development. Nat Rev Drug Discov 2012, 11:183-184.
2. Richards MA. The national awareness and early diagnosis initiative in England: assembling the evidence. Br J Cancer 2009, 101(Suppl 2):S1-4.
3. Caldas C. Cancer sequencing unravels clonal evolution. Nat Biotechnol 2012, 30:408-410.
4. Kim VN. Small RNAs: classification, biogenesis, and function. Mol Cells 2005, 19:1-15.
5. Weiland M, Gao XH, Zhou L, Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol 2012, 9:850-859.
6. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, et al. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 2010, 16:991-1006.
7. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166-185.
8. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
9. Lee EJ, Baek M, Gusev Y, Brackett DJ, Nuovo GJ, Schmittgen TD. Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 2008, 14:35-42.
10. Castellano L, Stebbing J. Deep sequencing of small RNAs identifies canonical and non-canonical miRNA and endogenous siRNAs in mammalian somatic tissues. Nucleic Acids Res 2013, 41:3339-3351.
11. Wang Y, Weng T, Gou D, Chen Z, Chintagari NR, Liu L. Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research. BMC Genomics 2007, 8:29-42.
12. Hoy AM, Buck AH. Extracellular small RNAs: what, where, why?. Biochem Soc Trans 2012, 40:886-890.
13. Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 2012, 37:460-465.
14. Sheinerman KS, Tsivinsky VG, Crawford F, Mullan MJ, Abdullah L, Umansky SR. Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY) 2012, 4:590-605.
15. Meyer SU, Pfaffl MW, Ulbrich SE. Normalization strategies for microRNA profiling experiments: a 'normal' way to a hidden layer of complexity?. Biotechnol Lett 2010, 32:1777-1788.
16. Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, et al. Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One 2012, 7:e32307.
17. Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res 2012, 18:4713-4724.
18. Eng J. Sample size estimation: how many individuals should be studied?. Radiology 2003, 227:309-313.
19. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
20. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, Lo YM. Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 2008, 54:482-490.
21. Russo F, Di Bella S, Nigita G, Macca V, Laganà A, Giugno R, et al. miRandola: extracellular circulating microRNAs database. PLoS One 2012, 7:e47786.
22. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3:e3694.
23. Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, Turchinovich A, et al. Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer 2013, 132:1602-1612.
24. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci USA 2011, 108:3713-3718.
25. Blair LP, Yan Q. Epigenetic mechanisms in commonly occurring cancers. DNA Cell Biol 2012, 31(Suppl 1):S49-61.
26. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011, 223:102-115.
27. Xie B, Ding Q, Han H, Wu D. miRCancer: a microRNA-cancer association database constructed by text mining on literature. Bioinformatics 2013, 29:638-644.
28. Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 2011, 157:163-179.
29. Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010, 31:37-49.
30. Benjamin H, Lebanony D, Rosenwald S, Cohen L, Gibori H, Barabash N, et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 2010, 12:771-779.
31. Rui W, Bing F, Hai-Zhu S, Wei D, Long-Bang C. Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1). J Cell Mol Med 2010, 14:206-214.
32. Kundu JK, Surh YJ. Emerging avenues linking inflammation and cancer. Free Radic Biol Med 2012, 52:2013-2037.
33. O'Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol 2012, 30:295-312.
34. Kanwar JR, Mahidhara G, Kanwar RK. MicroRNA in human cancer and chronic inflammatory diseases. Front Biosci (Schol Ed) 2010, 2:1113-1126.
35. Davidson-Moncada J, Papavasiliou FN, Tam W. MicroRNAs of the immune system: roles in inflammation and cancer. Ann NY Acad Sci 2010, 1183:183-194.
36. Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y, Guo H, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010, 56:1830-1838.
37. Tijsen AJ, Pinto YM, Creemers EE. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 2012, 303:H1085-1095.
38. Giordano S, Columbano A, MicroRNAs New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?. Hepatology 2013, 57:840-847. MicroRNAs.